ASD Homepage Research & Tracking Autism and Developmental Disabilities Monitoring (ADDM) Network The Autism and Developmental Disabilities Monitoring (ADDM) Network is a group of programs funded by CDC to estimate the number of children with autism spectrum disorder (ASD) and other developmental disabilities living in different areas of the United States. The ADDM Network sites all...
Post
Publication details IDRI’s promising leprosy vaccine candidate
A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI’s leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection against leprosy), alleviates and delays the neurologic disruptions caused by Mycobacterium lepraeinfection in nine-banded armadillos. This is an important finding because armadillos are the only other...
Post
UAB-led study shows drug effectiveness in reducing glucocorticoid-induced bone loss
The drug denosumab was superior to a commonly used drug in a 12-month study enrolling 795 patients UNIVERSITY OF ALABAMA AT BIRMINGHAM IMAGE: KEN SAAG BIRMINGHAM, Ala. – About one in every 100 people in the world takes glucocorticoids long term to treat immune-mediated diseases. However, glucocorticoids, such as prednisone, have a side effect — they...
Post
Music activates regions of the brain spared by Alzheimer’s disease
Ever get chills listening to a particularly moving piece of music? You can thank the salience network of the brain for that emotional joint. Surprisingly, this region also remains an island of remembrance that is spared from the ravages of Alzheimer’s disease. Diagram of brain networks involved in processing attention. Researchers at the University of Utah...
Post
The end of slings and crutches? ‘Extraordinary’ glue could soon fix broken bones in just 5 MINUTES
Swedish researchers claim it could help millions of patients with osteoporosis Experiments on rat bones showed the glue was successful at fixing fractures Further studies are needed to confirm it works in humans, the scientists said An ‘extraordinary’ glue that could fix broken bones in a matter of minutes has been developed by scientists. Swedish researchers claim it could...
Post
Scientists Get Their First Look at the Enzyme That Could Help Battle Aging
Nothing in your body lasts forever. Every single cell in your body will die eventually, and eventually, you’ll run out of replacements. When that happens, various parts of your body will stop working correctly, and at some point, the whole thing will shut down. Aging happens to all of us, and there’s nothing we can...
Post
CRISPR As Disease-Detector
Mammoth Biosciences, a company co-founded by CRISPR researcher Jennifer Doudna, has announced it is developing a platform to detect and diagnose disease using CRISPR technology, as GenomeWeb has reported. Company co-founder Trevor Martin from Stanford University tells the Verge that CRISPR isn’t just a gene-editing tool, but is “biology’s search engine.” The Verge adds that CRISPR can be...
Post
Largest-ever study of thyroid cancer genetics finds new mutations, suggests immunotherapy
University of Colorado Cancer Center researchers recently completed the largest-ever study of thyroid cancer genetics, mining the data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid cancers. In addition to the identification of specific genes that may drive these cancers and thus provide attractive targets for treatment, the researchers found that in several samples...
Post
Platelet-rich plasma for cosmetic facial procedures — promising results, but evidence has limitations
Most studies evaluating platelet-rich plasma (PRP) injection for facial rejuvenation and other cosmetic procedures have reported positive results, according to a critical review in the May issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS). But the research evidence supporting PRP for facial aesthetic procedures has important limitations – especially a lack...
Post
Protein responsible for Leukemia’s aggressiveness identified
(Boston)–Researchers have identified a protein critical for the aggressiveness of T-cell leukemia, a subtype of leukemia that afflicts children and adults. The identification of ubiquitin-fusion degradation 1 (UFD1) allows for better understanding what causes leukemia to progress and become highly aggressive and treatment-resistant, and may lead to a new treatment for this type of cancer. Leukemia...